These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38364330)

  • 41. Rectal cancer patients after neoadjuvant radiotherapy (30Gy/10f) with negative lymph node may not benefit from postoperative adjuvant chemotherapy: a retrospective study.
    Chen P; Yao Y; Gu J
    Int J Colorectal Dis; 2015 Dec; 30(12):1695-704. PubMed ID: 26278877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China.
    Wang X; Zheng Z; Zhu H; Yu Q; Huang S; Lu X; Huang Y; Chi P
    Int J Colorectal Dis; 2021 May; 36(5):1007-1016. PubMed ID: 33398511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of early complete response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy: Multicentric study of Turkish Society for Radiation Oncology Group (TROD).
    Kılıç D; Sert F; Görken İB; Arıcan Alıcıkuş Z; Aktürk N; Kaytan Sağlam E; Kizir A; Özkök S; Yılmaz HT; Göçen F; Yalman D
    Turk J Gastroenterol; 2020 May; 31(5):368-377. PubMed ID: 32519956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
    Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated CA19-9 as the Most Significant Prognostic Factor in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy.
    Zhang LN; OuYang PY; Xiao WW; Yu X; You KY; Zeng ZF; Xu RH; Gao YH
    Medicine (Baltimore); 2015 Nov; 94(45):e1793. PubMed ID: 26559251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High platelet × C-reactive protein level multiplier is a negative prognostic marker in rectal cancer treated by neoadjuvant chemoradiotherapy.
    Ide S; Toiyama Y; Okugawa Y; Shimura T; Fujikawa H; Hiro J; Ohi M; Kusunoki M
    Int J Clin Oncol; 2021 Apr; 26(4):708-716. PubMed ID: 33415573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.
    Lai SH; Vogel JD; Vemuru S; Messersmith W; Lieu C; McCarter MD; Birnbaum E; Chapman BC
    Dis Colon Rectum; 2023 Jul; 66(7):983-993. PubMed ID: 36602514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
    Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Baek JH; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kim JG
    In Vivo; 2020; 34(4):1993-1999. PubMed ID: 32606172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The neoadjuvant rectal score and a novel magnetic resonance imaging based neoadjuvant rectal score are stage independent predictors of long-term outcome in locally advanced rectal cancer.
    McMahon RK; O'Cathail SM; Nair H; Steele CW; Platt JJ; Digby M; McDonald AC; Horgan PG; Roxburgh CSD
    Colorectal Dis; 2023 Sep; 25(9):1783-1794. PubMed ID: 37485654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
    Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
    Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
    Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer.
    Jiang DM; Raissouni S; Mercer J; Kumar A; Goodwin R; Heng DY; Tang PA; Doll C; MacLean A; Powell E; Price-Hiller J; Monzon J; Cheung WY; Vickers MM
    Ann Oncol; 2015 Oct; 26(10):2102-6. PubMed ID: 26232491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.
    Cui J; Yang L; Guo L; Shao Y; Tan D; Li N; Zhang H
    Oncotarget; 2017 Jun; 8(23):37845-37854. PubMed ID: 28103579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of total neoadjuvant therapy consisting of consolidation chemotherapy on locally advanced rectal cancer survival.
    Zhang H; Li G; Cao K; Zhai Z; Wei G; Qu H; Wang Z; Han J
    Int J Colorectal Dis; 2022 Jul; 37(7):1657-1668. PubMed ID: 35716183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
    Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
    World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Total neoadjuvant therapy for locally advanced rectal cancer: a three-group propensity score matched study.
    Zhou J; Huang J; Zhou Z; Deng X; Wu Q; Wang Z
    Int J Colorectal Dis; 2024 Mar; 39(1):38. PubMed ID: 38492080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
    Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
    BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Presence and clinical significance of acellular mucin pools in resected rectal cancer with pathological complete response after pre-operative chemoradiotherapy.
    Chen M; Lin H; Zhang J; Pang X; Fan X; Luo S; Liu Z; Hu H; Lai S; Hou Y; Kang L; Huang L
    Histopathology; 2022 Nov; 81(5):569-576. PubMed ID: 36104077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.